Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis.
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2012
At a glance
- Drugs Ticagrelor (Primary)
- Indications Cardiovascular disorders; Embolism and thrombosis; Myocardial infarction; Stroke
- Focus Pharmacodynamics
- 02 Feb 2012 Actual patient number is 20 according to ClinicalTrials.gov.
- 01 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.